Cargando…

Cerebrospinal fluid evaluation in patients with progressive motor impairment due to critical central nervous system demyelinating lesions

BACKGROUND: Elevated intrathecal immunoglobulin G (IgG; oligoclonal bands (OCBs)) or IgG in people with progressive motor impairment due to “critical” demyelinating lesions are of uncertain significance. OBJECTIVE: Compare clinical/radiological features of people with “critical” demyelinating lesion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barakat, Benan, Messina, Steve, Nayak, Shreya, Kassa, Roman, Sechi, Elia, Flanagan, Eoin P, Kantarci, Orhun, Weinshenker, Brian G, Keegan, B. Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761886/ https://www.ncbi.nlm.nih.gov/pubmed/35047187 http://dx.doi.org/10.1177/20552173211052159

Ejemplares similares

Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders
por: Sechi, Elia, et al.
Publicado: (2021)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events
por: Kunchok, Amy, et al.
Publicado: (2020)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
por: Fadda, Giulia, et al.
Publicado: (2022)

CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies
por: Zhao-Fleming, Hannah H., et al.
Publicado: (2021)

Population-based study of “no evident disease activity” in MS
por: Parks, Natalie E., et al.
Publicado: (2018)

Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI
por: Zara, Pietro, et al.
Publicado: (2021)

Cerebrospinal fluid in diseases of the nervous system /
por: Fishman, Robert A.
Publicado: (1992)

Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management
por: Sechi, Elia, et al.
Publicado: (2021)

Cerebrospinal fluid protein carbonylation identifies oxidative damage in autoimmune demyelination
por: Irani, David N.
Publicado: (2016)

Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
por: Iriyama, Chisako, et al.
Publicado: (2023)

Cerebrospinal Fluid and Central Nervous System Cytology
por: Levine, Gwendolyn J., et al.
Publicado: (2020)

Editorial: Immune-mediated disorders of the spinal cord: Diagnosis, treatment strategies, and outcomes in the 21st century
por: Fadda, Giulia, et al.
Publicado: (2022)

Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective
por: Arslan, Burak, et al.
Publicado: (2022)

Reproductive history and progressive multiple sclerosis risk in women
por: Zeydan, Burcu, et al.
Publicado: (2020)

Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
por: Modvig, Signe, et al.
Publicado: (2013)

Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases
por: Hofer, Livia S, et al.
Publicado: (2019)

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndrome
por: Péter, Mária, et al.
Publicado: (2020)

Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression
por: Banks, Samantha A., et al.
Publicado: (2021)

Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective
Publicado: (2023)

The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020)

First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease
por: Domingues, Renan Barros, et al.
Publicado: (2020)

Cervical spinal cord atrophy: An early marker of progressive MS onset
por: Zeydan, Burcu, et al.
Publicado: (2018)

Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
por: Wullschleger, Alexandre, et al.
Publicado: (2013)

Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system
por: Cinque, Paola, et al.
Publicado: (2003)

Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders
por: Mariani, Christopher L., et al.
Publicado: (2019)

Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid
por: Peters, Kristian, et al.
Publicado: (2021)

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid
por: Douville, Christopher, et al.
Publicado: (2023)

Demyelinating Disorders of the Central Nervous System
por: Pirko, Istvan, et al.
Publicado: (2007)

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system
por: French, Caitlin D., et al.
Publicado: (2018)

Expression of microRNAs in cerebrospinal fluid of dogs with central nervous system disease
por: Marioni-Henry, Katia, et al.
Publicado: (2018)

Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas
por: Zajdel, Michalina, et al.
Publicado: (2019)

Development of the Cerebrospinal Fluid in Early Stage after Hemorrhage in the Central Nervous System
por: Kelbich, Petr, et al.
Publicado: (2021)

Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
por: Yan, Jingya, et al.
Publicado: (2021)

A new dawn for genetic association studies in multiple sclerosis
por: Kantarci, Orhun H.
Publicado: (2016)

B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination
por: Kothur, Kavitha, et al.
Publicado: (2016)

Neurodegeneration and humoral response proteins in cerebrospinal fluid associate with pediatric-onset multiple sclerosis and not monophasic demyelinating syndromes in childhood
por: Bruijstens, Arlette L, et al.
Publicado: (2022)

Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018)

Research into the Physiology of Cerebrospinal Fluid Reaches a New Horizon: Intimate Exchange between Cerebrospinal Fluid and Interstitial Fluid May Contribute to Maintenance of Homeostasis in the Central Nervous System
por: MATSUMAE, Mitsunori, et al.
Publicado: (2016)

Cerebrospinal Fluid
por: Bailey, Cleta Sue, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_63048acekc4h8514fa01etbo1s